Triptans are one class, or group, of medications that can treat migraine attacks after they start. Triptans cannot prevent a migraine attack from happening. Instead, these medications help relieve ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Some people experience a collection of symptoms called aura before a migraine attack. A variety of medications can treat or prevent migraine. Over-the-counter (OTC) pain medications are often used ...

The medication’s effectiveness stems from its targeted approach to migraine prevention. Atogepant specifically acts on blood vessels involved in migraine attacks, preventing excessive dilation ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

Topamax (topiramate) is an anti-seizure medication that may be prescribed to prevent certain types of migraine headaches for adults and adolescents age 12 and older. A migraine is more severe than a ...

as well as for acute treatment of migraine attacks. The Migraine Trust said that the new drugs are important new options for people who have not had success with other preventive medications ...

How should she be evaluated and treated? What is the probable migraine type and the drug of choice for its treatment and long-term management?

There are several agents for prevention of migraine occurrence in patients with frequent or severe disabling migraine attacks. New drugs with improved efficacy and reduced side effects are needed ...

Medicines can help you manage, prevent ... of headache medications? OTC headache medicines may cause an upset stomach or heartburn. Long-term use of some OTC or prescription migraine medicines ...

The drug was turned down by NICE in February as an acute treatment for migraine in draft guidance, although it won’t make a final decision on that use until later this year. The decision was ...